definiens: shall mean any invention or Technology thatwould be a Collaboration Invention ( except for the exclusion set forth therein ) and thatrelates to ( a ) the composition of matter of the [COMPANY] Compound ( and not the BioXcelCompound or CPI Compound ), ( b ) method of manufacture or formulation of the NektarCompound ( and not the BioXcel Compound or the CPI Compound ) as a single agent, and/or ( c ) a method of use of the [COMPANY] Compound ( and not the BioXcel Compound)as a monotherapy or in combination with the CPI Compound ( and not the BioXcelCompound ) or other agents, antibodies or compounds ( other than a CollaborationInvention comprising, whether generically or specifically, the use of the CPICompound ( and/or any other antibodies that are designed to selectively bind to PD-1or PD - L1 ), the [COMPANY] Compound ( and/or any other IL2 - based CD122 agonist ), and aBioXcel Compound ( and/or any other inhibitor of dipeptidyl peptidase 8 - 9 ( DPP8 - 9)and fibroblast activation protein ( FAP))).1.55 shall mean any Patent Rights that areControlled by [COMPANY] and Cover any [COMPANY] Study Invention ( and not a BioXcel StudyInvention or Combined Therapy Trial Invention ) or [COMPANY] Study Data, excludingNektar Independent Patent Rights and [COMPANY] Technology